- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT01801657
The Role of Viral Infection in Acute Exacerbations of Non-cystic Fibrosis Bronchiectasis in Adults
연구 개요
상태
정황
상세 설명
Bronchiectasis is a chronic airway disease characterised by a vicious cycle of persistent bacterial colonization,inflammation and progressive tissue destruction.Patients with bronchiectasis frequently developed acute exacerbations characterised by acute worsening requiring changes in concomitant use of medication,with attendant adverse effects on their morbidity and health-related quality of life. The detailed pathogenesis of exacerbations of bronchiectasis, however, remains poorly understood.
Recent data suggested that airway infection and inflammation are important drivers of exacerbations,therefore the imbalance between chronic bacterial infection and host immune response may result in bronchiectasis exacerbations. Viral infection may be an important factor that leads to this events.It has been established that respiratory viruses are mainly responsible for the exacerbations of other chronic respiratory diseases, i.e. asthma, COPD and cystic fibosis. However, the data regarding prospective studies that sought to investigate the roles of viruses in acute exacerbation of bronchiectasis are lacking. Furthermore,the associations between viruses and bacteria during exacerbation need to be assessed. This study targets at indentifying the frenquency of common viral infections in adults with non-cystic fibrosis bronchiectasis and may shed light on the effects they have on clinical parameters,i.e. the length of exacerbated symptom to recovery,lung function, pulmonary inflammation, bacterial load and quality of life.
연구 유형
등록 (예상)
연락처 및 위치
연구 연락처
- 이름: Rongchang Chen, MD
- 전화번호: 020-83062718
- 이메일: Chenrc@vip.163.com
연구 연락처 백업
- 이름: Nanshan Zhong, MD
- 전화번호: 020-83062718
- 이메일: nanshan@vip.163.com
연구 장소
-
-
Guangdong
-
Guangzhou, Guangdong, 중국, 510000
- 모병
- The First Affiliated Hospital of Guangzhou Medical University
-
연락하다:
- Rongchang Chen, MD
- 전화번호: 020-83062718
- 이메일: Chenrc@vip.163.com
-
연락하다:
- Nanshan Zhong, MD
- 전화번호: 020-83062718
- 이메일: nanshan@vip.163.com
-
부수사관:
- Yonghua Gao, PHD
-
부수사관:
- Gang Xu, PHD
-
부수사관:
- Weijie Guan, PHD
-
부수사관:
- Zhiya Lin, PHD
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
설명
Inclusion Criteria:
- Age ≥ 18 years
- HRCT-diagnosed Bronchiectasis
- Capable of providing written informed consent
Exclusion Criteria:
- Patient judged to have poor compliance
- Cystic fibrosis bronchiectasis
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
코호트 및 개입
그룹/코호트 |
---|
Bronchiectasis,stable
A patient was defined as stable if there was no exacerbation for the previous 4 wk
|
Bronchiectasis,exacerbations
Bronchiectasis exacerbations were defined by subjective and persistent(>24 h) deterioration in at least three respiratory symptoms, including cough, dyspnea, hemoptysis, increased sputum purulence or volume, chest pain (with or without fever), radiographic deterioration, systemic disturbances, or changes in chest auscultation
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
The prevalence of respiratory virus infection in adults with bronchiectasis during a pulmonary exacerbation and when clinically stable.
기간: 1 year
|
Respiratory viruses in the nasal swab and sputum will be identified using the polymerase chain reaction(PCR)technique when clinically stable and during exacerbation.The following viruses will be tested for:influenza A,B(including influenza A H1N1),respiratory syncytial virus(RSV),Enterovirus,Parainfluenza 1-4,Rhinovirus,human Coronaviruses(subtypes OC43、229E、HKU1),human metapneumovirus,adenovirus, human bocavirus,chlamydia,mycoplasma.
|
1 year
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
The effect of respiratory virus infection on systemic and pulmonary inflammatory markers.
기간: 1 year
|
Systemic and airway inflammatory cytokines including IL-1β、IL-6、IL-8、TNF-a were measured using a commercial multiplex bead-based assay.
|
1 year
|
The effect of respiratory virus on lung function
기간: 1 year
|
Spirometric indices in the present study is referred to as forced expiratory vilume in 1s(FEV1),forced vital capacity(FVC).Spirometry tests are carried out using a spirometer (COSMED, QUARK PFT, Italy).
All operation procedures meet the joint recommendation by ATS and ERS.
A total of at least 3 (not more than 8) spirometric maneuvers are performed, with the variation between the best two maneuvers of <5% or 200ml in FVC and FEV1.
The maximal values of FVC and FEV1 are reported.
|
1 year
|
The effect of respiratory virus infection on the bacterial load in bronchiectasis.
기간: 1 year
|
Type of bacterial infection, also referred to as potentially pathogenic organisms, and bacterial load, as expressed in cfu per mililiter
|
1 year
|
Time to recovery of respective symptom
기간: 1 year
|
The time from exacerbation onset by which a 3-d moving average was equal to or exceeded the baseline value
|
1 year
|
The effect of respiratory virus on quality of life in patients with bronchiectasis
기간: 1 year
|
Quality of life in patients with bronchiectasis were measured by St.George Respiratory Questionnaire、Leicester Cough Questionnaire and COPD assessment test during exacerbations,and then compared between virus-postive and virus-negative patients
|
1 year
|
To investigate if upper respiratory tract symptoms are associated with viral infections.
기간: 1 year
|
1 year
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Nanshan Zhong, MD, The First Affiliated Hospital of Guangzhou Medical University
- 수석 연구원: Rongchang Chen, MD, The First Affiliated Hospital of Guangzhou Medical University
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (예상)
연구 완료 (예상)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .